目的探讨肿瘤放射增敏剂希美钠在鼻咽癌放射治疗的增敏作用和临床价值。
Objective To discuss the clinical value and sensitizing effect of tumor radiosensitizer in the radiation therapy of Nasopharyngeal Carcinoma.
结论后装放射治疗鼻咽肿瘤残留病灶有较好的疗效，特别对早期病人。
Conclusion Brachytherapy is effective in the treatment of the residual nasopharyngeal neoplasms, especially for patients at an early stage.
探讨放射治疗联合腔内热疗治疗鼻咽肿瘤的耐受性、副反应和局部控制率。
To evaluate the tolerance, side effect, and local control rate for nasopharyngeal carcinoma (NPC) treated with radiotherapy combined with intracavity hyperthermia.
方法120例均经病理证实的鼻咽肿瘤经外照射全量后复查，确定腔内仍有残留病灶者，给予后装放射治疗15 -30gy。
Methods 120 cases all proved as nasopharyngeal neoplasms were treated with brachytherapy (15 ~ 30gy). These cases all had intracavitary residual tumors after full external radiation therapy.
方法120例均经病理证实的鼻咽肿瘤经外照射全量后复查，确定腔内仍有残留病灶者，给予后装放射治疗15 -30gy。
Methods 120 cases all proved as nasopharyngeal neoplasms were treated with brachytherapy (15 ~ 30gy). These cases all had intracavitary residual tumors after full external radiation therapy.
应用推荐